✦ LIBER ✦
Bortezomib Added to Daunorubicin and Cytarabine During Induction Therapy and to Intermediate-Dose Cytarabine for Consolidation in Patients With Previously Untreated Acute Myeloid Leukemia Age 60 to 75 Years: CALGB (Alliance) Study 10502
✍ Scribed by Attar, E. C.; Johnson, J. L.; Amrein, P. C.; Lozanski, G.; Wadleigh, M.; DeAngelo, D. J.; Kolitz, J. E.; Powell, B. L.; Voorhees, P.; Wang, E. S.; Blum, W.; Stone, R. M.; Marcucci, G.; Bloomfield, C. D.; Moser, B.; Larson, R. A.
- Book ID
- 126793022
- Publisher
- American Society of Clinical Oncology
- Year
- 2013
- Tongue
- English
- Weight
- 230 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0732-183X
No coin nor oath required. For personal study only.